Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas-Reference-Cited by-同舟云学术

Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas

Published:2013-02-07 Issue:5 Volume:15 Page:595-606
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Pallud Johan,Blonski Marie,Mandonnet Emmanuel,Audureau Etienne,Fontaine Denys,Sanai Nader,Bauchet Luc,Peruzzi Philippe,Frénay Marc,Colin Philippe,Guillevin Rémy,Bernier Valérie,Baron Marie-Hélène,Guyotat Jacques,Duffau Hugues,Taillandier Luc,Capelle Laurent

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/15/5/595/12772665/nos331.pdf

Reference30 articles.

1. Oligodendroglioma;Reifenberger,2007

2. Diffuse astrocytomas;von Deimling,2007

3. Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force;Soffietti;Eur J Neurol,2010

4. Continuous growth of mean tumor diameter in a subset of grade II gliomas;Mandonnet;Annals of Neurology,2003

5. Natural history of incidental World Health Organization grade II gliomas;Pallud;Annals of Neurology,2010

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A disulfidptosis-associated long noncoding RNA signature to predict low-grade glioma classification, prognosis, tumor microenvironment, and therapy regimens: Observational study;Medicine;2024-08-23

2. From molecular signatures to radiomics: tailoring neurooncological strategies through forecasting of glioma growth;Neurosurgical Focus;2024-02

3. Radiographic growth rate as a predictor of aggressiveness of diffuse gliomas without 1p19q codeletion;Neurosurgical Focus;2024-02

4. Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma—Response;Clinical Cancer Research;2024-02-01

5. Integrated analysis of necroptosis related gene signature to predict clinical outcomes, immune status and drug sensitivity in lower grade Glioma;Heliyon;2024-01